21 June 2011
Advanced Retinal Therapy will be held in Vienna, Austria on 3 December 2011. At this event updates, trends and controversies in retinal tehrapy will be discussed in symposia, key-note lectures and a panel discussion session.
 |
01 June 2011
By:Dr Neil M. Bressler
The answer may be found in the masking effects of catract upon pre-existing disease
|
01 June 2011
By:Dr Dennis M. Marcus
Anti-vascular endothelial growth factor agent well-tolerated, met primary efficacy endpoint.
|
01 May 2011
By:Dr Sunir J. Garg
Dr Sunir Gard reveals some of the more common problems that can be encountered with MIVS and how to cope with them.
|
01 April 2011
By:Professor Robyn Guymer
A novel nanosecond laser therapy has stopped the progression of age-related macular degeneration (AMD) and resulted in resolution of drusen and improved visual function in patients with early-stage high-risk AMD.
|
01 March 2011
By: Dr Stephanie Hagstrom, PhD
Combined genomic and proteomic biomarkers are seemingly the most effective method for predicting progression.
|
01 January 2011
By:Dr Thomas A. Ciulla
The efficacy and safety of two doses of a fluocinolone acetonide intravitreal insert for the treatment of DME were investigated in two sham-controlled phase III studies
|
| 
